Browsing Tag
Tempus AI
14 posts
Tech and AI stocks plunge as market selloff hits Core Scientific, Vertiv, Root, and more
Tech and AI stocks tumbled on March 26, 2025, as trade tariffs and market uncertainty triggered a selloff. Find out which stocks were the biggest losers.
Tempus AI and Stemline Therapeutics partner to advance AI-driven ESR1 mutation testing in metastatic breast cancer
Tempus AI, Inc. (NASDAQ: TEM) and Stemline Therapeutics, Inc., a wholly owned subsidiary of the Menarini Group, have…
Tempus AI stock soars 14% after FDA approval of xT CDx test
Tempus AI, a leader in healthcare technology, has unveiled its FDA-approved in vitro diagnostic device, xT CDx, marking…
Tempus AI shakes up precision medicine with $600m acquisition of Ambry Genetics
Tempus AI has taken a significant step in advancing its precision medicine strategy by agreeing to acquire Ambry…